Physician

Alexander Babazadeh, M.D.

According to 2025 Medicare claims, Alexander Babazadeh, M.D. (NPI: 1285088815) practices allergy/immunology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from New York, NY. This provider's primary affiliated billing organization is 14 STREET MEDICAL, PC (NPI: 1386091486; TIN: 812658803) and primary practice location at 10025-4040.

Babazadeh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 52 traditional Medicare patients, billed 1,609 HCPCS/CPT codes, and received $7,692 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 427 prescription claims across 68 beneficiaries totaling $75,665 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). Open Payments data shows 94 records totaling $4,158. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $490 to $75,665. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$3.8K$7.7K2024 Medicare payment: $7,692 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024521,609$7,692

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$38K$76K2020 Drug cost: $490 (USD; Tot_Drug_Cst)2021 Drug cost: $9,341 (USD; Tot_Drug_Cst)2022 Drug cost: $33,237 (USD; Tot_Drug_Cst)2023 Drug cost: $20,448 (USD; Tot_Drug_Cst)2024 Drug cost: $75,665 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/R24$490
202130136$9,341
202236136$33,237
202346206$20,448
202468427$75,665

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more1111$149
95004Test for allergy using allergenic extract481,590$3

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19570$11,786
EpinephrineEpinephrine24416$4,593
Albuterol Sulfate HfaAlbuterol Sulfate651,625$1,731
Azelastine HclAzelastine Hcl722,245$1,281
Wixela InhubFluticasone Propion/Salmeterol13510$1,269

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.94$4,158AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alexander Babazadeh, M.D.?

Tedicare shows public-source Medicare data for Alexander Babazadeh, M.D. (NPI 1285088815), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexander Babazadeh, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alexander Babazadeh, M.D.?

Alexander Babazadeh, M.D. is linked to 14 STREET MEDICAL, PC (billing NPI 1386091486) in the available physician profile data.

Does Alexander Babazadeh, M.D. have Open Payments data?

Alexander Babazadeh, M.D. has 94 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.